Literature DB >> 22669396

[Organ-sparing chemoradiotherapy: a viable alternative to initial cystectomy for patients with muscle-invasive bladder cancer].

C Weiss1, R Sauer.   

Abstract

Entities:  

Year:  2012        PMID： 22669396     DOI： 10.1007/s00066-012-0152-x

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  15 in total

1.  15-year survival rates after transurethral resection and radiochemotherapy or radiation in bladder cancer treatment.

Authors:  Frens Steffen Krause; Bernhard Walter; Oliver Josef Ott; Lothar Häberle; Christian Weiss; Claus Rödel; Bernd Wullich; Rolf Sauer
Journal:  Anticancer Res       Date:  2011-03       Impact factor: 2.480

2.  Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

Authors:  J P Stein; G Lieskovsky; R Cote; S Groshen; A C Feng; S Boyd; E Skinner; B Bochner; D Thangathurai; M Mikhail; D Raghavan; D G Skinner
Journal:  J Clin Oncol       Date:  2001-02-01       Impact factor: 44.544

3.  Whole-pelvis or bladder-only chemoradiation for lymph node-negative invasive bladder cancer: single-institution experience.

Authors:  Mutahir A Tunio; Altaf Hashmi; Abdul Qayyum; Rehan Mohsin; Ahmed Zaeem
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-09-22       Impact factor: 7.038

4.  Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research.

Authors: 
Journal:  Lancet       Date:  1996-10-19       Impact factor: 79.321

5.  Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy.

Authors:  Stephan Madersbacher; Werner Hochreiter; Fiona Burkhard; George N Thalmann; Hansjörg Danuser; Regula Markwalder; Urs E Studer
Journal:  J Clin Oncol       Date:  2003-02-15       Impact factor: 44.544

6.  Use of radical cystectomy for patients with invasive bladder cancer.

Authors:  John L Gore; Mark S Litwin; Julie Lai; Elizabeth M Yano; Rodger Madison; Claude Setodji; John L Adams; Christopher S Saigal
Journal:  J Natl Cancer Inst       Date:  2010-04-16       Impact factor: 13.506

Review 7.  Trimodality treatment and selective organ preservation for bladder cancer.

Authors:  Claus Rödel; Christian Weiss; Rolf Sauer
Journal:  J Clin Oncol       Date:  2006-12-10       Impact factor: 44.544

8.  Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer.

Authors:  Nicholas D James; Syed A Hussain; Emma Hall; Peter Jenkins; Jean Tremlett; Christine Rawlings; Malcolm Crundwell; Bruce Sizer; Thiagarajan Sreenivasan; Carey Hendron; Rebecca Lewis; Rachel Waters; Robert A Huddart
Journal:  N Engl J Med       Date:  2012-04-19       Impact factor: 91.245

Review 9.  Complications following radical cystectomy for bladder cancer in the elderly.

Authors:  Michael Froehner; Maurizio A Brausi; Harry W Herr; Giovanni Muto; Urs E Studer
Journal:  Eur Urol       Date:  2009-05-18       Impact factor: 20.096

10.  Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results.

Authors:  Claus Rödel; Gerhard G Grabenbauer; Reinhard Kühn; Thomas Papadopoulos; Jürgen Dunst; Martin Meyer; Karl M Schrott; Rolf Sauer
Journal:  J Clin Oncol       Date:  2002-07-15       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.